Search

Dec 02, 2024
2024 Judicial Review: Significant Court Decisions on Medical Liability Issues
Dennis Chiu, JD, Senior Government Relations Specialist, The Doctors Company
Between fall 2023 and summer 2024, state supreme courts handed down mixed decisions on medical liability issues affecting healthcare professionals.
From The Doctor’s Advocate

Mar 07, 2023
In Memoriam: Donald J. Palmisano, MD, JD, FACS
It is with great sadness that we report the passing of long-time Board Member Donald J. Palmisano, MD, JD, FACS.
From The Doctor’s Advocate

Sep 05, 2025
The Foundation Board Welcomes New Director Ami Parekh, MD, JD
We’re pleased to welcome Ami Parekh, MD, JD, to The Doctors Company Foundation Board of Directors. Dr. Parekh is the Chief Health Officer at Included Health, where she leads their national primary care, urgent care, behavioral health, clinical navigation, and population health management practices.
From The Doctor’s Advocate

May 20, 2024, Part B News
CMS: In AWV, SDOH Assessment Can Occur Days Before Visit; Append Modifier
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses a Change Request pertaining to the use of social determinants of health (SDOH) risk assessments during Medicare annual wellness visits (AWV).

Remote Patient Monitoring and Telehealth Care
Remote patient monitoring is advancing the safety and accuracy of telehealth by filling in some gaps and increasing the types of care that can safely be provided in the home.

Medical Advantage Sale
The Doctors Company, part of TDC Group, today announced that it has sold its Medical Advantage subsidiary to Aledade, the nation’s largest network of physician-led value-based care.

Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Plastic Surgery Closed Claims Study
In this study of plastic surgery closed claims, The Doctors Company looks at the most common case types, most common patient injuries, primary drivers / frequent allegations, and strategies for mitigating risk for both cosmetic and reconstructive surgery.

Jun 18, 2024
Industry and Company News Second Quarter 2024
The second quarter 2024 issue includes announcements about a member dividend and the appointment of our new chief operating officer.
From The Doctor’s Advocate

AI, COVID-19, and Future Pandemics
Artificial intelligence (AI) has proven of value in the COVID-19 pandemic and shows promise for mitigating future healthcare crises.